Article Text


997 Ventilator-Associated Pneumonia (VAP) on Pediatric Intensive Care Unit
  1. JR Fedžat,
  2. F Jonuzi,
  3. V Mišanovic´,
  4. D Anic´,
  5. M Halimic´,
  6. A Jonuzi
  1. PICU, Pediatric Clinic, University Clinical Centre of Sarajevo, Sarajevo, Bosnia-Herzegovina


Introduction Ventilator-associated pneumonia (VAP) is a form of nosocomial infections - pneumonia which occurs in patients who are on mechanical ventilation for longer than 48 hours. It is very often complication on intensive unit care.

Aim To evaluate prevalence VAP on Paediatric intensive care unit (PICU) and the most common causes. Subjects and methods: From mart 2009. till mart 2011., 42 patients age two months to eight years. Design of study: prospective Patients were divided according to age, gender, time of manifestations VAP, types of microorganisms isolated in cultures.

Results From 42 investigated patients 22/42 (52.3%) were females. Patients were divided in the groups according to their age as follows: 0–6 months 9/42 (21.4%), 7–12 months 17/42 (40.4%), 1–3 years 11/42 (24.4%), 4–8 years 5/42 (11.9%)patients. According to time of manifestations VAP: between 48–96 hours of ventilations 14/42 (33.3%) patients, after 96 hours of ventilations 14/42 (33.3%) patients. According to types of microorganismus isolated in cultures: Klebsiella pneumoniae 12/42 (28.5%), Acinetobacter calcoaceticus 7/42 (16.6%), Staphylococcus aureus 7/42 (16.6%), Pseudomonas aeraginosa 4/42 (9.5%), Enterobacter4/42 (9.5%), Stenotrophomonas maltophilia 2/42 (4.7%), unknown 8/42 (19.2%).De-escalation therapy was administered in 30/42 (71.4%) patients. Dual antibiotic therapy was found in 22/42 (52.3%) patients. Mortality was 13/42 (30.9%) patients, in group therapy with deeskalation 7/13 (53.8%), whereas in the monotherapy group was 8/13 (61.5%) patients.

Conclusion VAP is quite common complication on PICU. Previously taken cultures are very helpful in s timely selection antibiotics and successful recovery.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.